| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5cb598f30390aa500e45575bc3daddd |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2021-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1652c045a46fca646e8d4c9a797cde10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c9dc861a3e2ed66ed53379756288f37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d84cec9c8ae0203fcf2ed088780b702
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb00dbf289e9a0251051bce02057b410
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d25baa6f5b121364f39290090f299b7 |
| publicationDate |
2021-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021220133-A1 |
| titleOfInvention |
Novel multiparticulate pharmaceutical composition of tamsulosin and solifenacin |
| abstract |
The present invention relates to a novel multiparticulate pharmaceutical composition for oral administration with a controlled dissolution rate. The composition comprises Tamsulosin hydrochloride in modified release form and Solifenacin succinate in immediate release form, wherein the core comprises Tamsulosin hydrochloride and an outer immediate layer comprises Solifenacin succinate. According to the present invention, the instant formulation release the drug at predetermined rate and prevent dose dumping as well as improving the patient compliance. |
| priorityDate |
2020-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |